MDL | MFCD00008747 |
---|---|
Molecular Weight | 166.17 |
Molecular Formula | C9H10O3 |
SMILES | CC(C1=CC=C(O)C(OC)=C1)=O |
Apocynin is a selective NADPH-oxidase inhibitor with an IC 50 of 10 μM.
NCT Number | Sponsor | Condition | Start Date | Phase |
---|---|---|---|---|
NCT03680404 | The University of Texas at Arlington |
Cardiovascular Diseases|Cardiovascular Risk Factor|Vasoconstriction
|
October 1, 2018 | Phase 1 |
NCT03680573 | The University of Texas at Arlington |
Cardiovascular Diseases|Cardiovascular Risk Factor|Vasoconstriction
|
January 8, 2018 | Phase 1 |
NCT03680638 | The University of Texas at Arlington |
Cardiovascular Diseases|Cardiovascular Risk Factor|Vasodilation
|
September 7, 2016 | Phase 1 |
NCT00992667 | Medical University of Lodz|Ministry of Science and Higher Education, Poland |
Bronchial Asthma
|
June 2008 | Phase 1 |
NCT01402297 | Medical University of Lodz|Ministry of Science and Higher Education, Poland |
Chronic Obstructive Pulmonary Disease
|
October 2010 | Phase 1 |
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : ≥ 100 mg/mL ( 601.79 mM )
H 2 O : ≥ mg/mL
* "≥" means soluble, but saturation unknown.
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 6.0179 mL | 30.0897 mL | 60.1793 mL |
5 mM | 1.2036 mL | 6.0179 mL | 12.0359 mL |
10 mM | 0.6018 mL | 3.0090 mL | 6.0179 mL |